Sore throat, loss of smell and taste, headache and myalgia were specific to the 18-49 age group (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: In this study, we determined the symptoms of the COVID-19 and defined agespecific symptoms that can help diagnose the disease on hospital admission.
📊
Key Findings & Data:Materials and Methods: Patients who visited a university hospital’s adult pandemia outpatient clinic with suspected COVID-19 symptoms and tested with SARS-CoV-2 polymerase chain reaction test between March 17 – May 17, 2020, were included in the study.
💡
Conclusion & Impact:Sore throat, loss of smell and taste, headache and myalgia were specific to the 18-49 age group (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters
Abstract
Objective: In this study, we determined the symptoms of the COVID-19 and defined agespecific symptoms that can help diagnose the disease on hospital admission. Materials and Methods: Patients who visited a university hospital’s adult pandemia outpatient clinic with suspected COVID-19 symptoms and tested with SARS-CoV-2 polymerase chain reaction test between March 17 – May 17, 2020, were included in the study. Demographic data, symptoms on admission, prognostic laboratory tests and hospitalization were recorded. Results: Out of 5289 admissions, 639 (12.1%) patients had suspected or confirmed COVID-19. Patients were sorted incident to age groups to determine the difference in demographic data, comorbidities, symptoms, prognostic laboratory findings and outcome. The exposure history was lower in the 65-79 age group, contrary to the ≥ 80 age group. Sore throat, loss of smell and taste, headache and myalgia were specific to the 18-49 age group (p
🔖
Cite This Article
KUTSOYLU, O. Ö. E., APPAK, Ö., OĞUZ, V. A., ZEKA, A. N., YAPAR, N., ORAY, N. Ç., ALPAYDIN, A. Ö., ŞİMŞEK, G. Ö., BAYRAM, B. (2022). Comparison of Clinical Characteristics and Prognostic Laboratory Findings of COVID-19 Patients by Age Groups. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 3, 120–128. https://ajindex.com/articles/539087
1 WHO Coronavirus (COVID-19) Dashboard [Internet]. (cited August 15, 2021). Available from: https://covid19.who.int/ 2 Rebuplic of Turkey Ministry of Health COVID-19 Information Page [Internet]. (cited August 15, 2021). Available from: https:// covid19.saglik.gov.tr/?_Dil=2. 3 Ferreira- Santos D, Maranhao P, Monteiro- Soares M. Identifying common baseline clinical features of COVID-19: A scoping review. BMJ Open. 2020
10(9):e041079. [CrossRef] 4 Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q et al. Prevalence of comorbidities and its effects in patients infected with SARSCoV- 2: A systematic review and meta-analysis. Int J Infect Dis. 2020
91–5. [CrossRef] 5 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
395(10223):497-506. [CrossRef] 6 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020
395(10229):1054-62. [CrossRef] 7 Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020
323(20):2089- 90. [CrossRef] 8 Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
382(18):1708-20. [CrossRef] 9 Liu X, Lv J, Gan L, Zhang Y, Sun F, Meng B et al. Comparative analysis of clinical characteristics, imaging and laboratory findings of different age groups with COVID-19. Indian J Med Microbiol. 2020
[CrossRef] 10 COVID-19 (SARS-CoV-2 Enfeksiyonu) Erişkin Hasta Tedavisi Rehberi. Bilimsel Danışma Kurulu Çalışması [Internet]. T.C. Sağlık Bakanlığı COVID-19 Bilgilendirme Platformu.(May 7, 2021
cited August 15, 2021). Turkish. Available from: https:// covid19.saglik.gov.tr/TR-66926/eriskin-hasta-tedavisi.html. 11 COVID-19 [Internet]. CDC web page. (cited August 15, 2021). Available from: https://www.cdc.gov/coronavirus/2019-ncov/ index.html. 12 Macedo MCF, Pinheiro IM, Carvalho CJL, Fraga HCJR, Araujo IPC, Montes SS et al. Correlation between hospitalized patients’ demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil. PLoS One. 2020
15(12):e0243966. [CrossRef] 13 Bastug A, Bodur H, Erdogan S, Gokcinar D, Kazancioglu S, Kosovali BD et al. Clinical and laboratory features of COVID-19: Predictors of severe prognosis.